What is the mechanism of action of the sipuleucel-T prostate cancer vaccine?
A) Dendritic cells are incubated with a fusion protein containing prostate specific antigen (PSA) and GM-CSF.
B) A plasmid that codes for an antibody that expresses prostate specific antigen (PSA) , and dendritic cells present PSA to T cells.
C) A single B cell clone that is tumor specific is grown in the lab and infused into the patient to produce large amounts of tumor specific antibody.
D) Patient tumor cells are exposed to a viral vector containing a gene for prostate specific antigen (PSA) , and then the tumor cells are infused into the patient to stimulate an immune response.
Correct Answer:
Verified
Q1: Which of the following is an outcome
Q2: Which is one disadvantage to cell-based anticancer
Q3: What is one role that type I
Q4: NY-ESO-1 would be a beneficial addition to
Q5: A defect in production of cryopyrin leads
Q6: Oprelvekin increases levels of:
A) Platelets
B) Neutrophils
C) Macrophages
D)
Q8: Recombinant IL-2 administration is appropriate for the
Q9: Which of the following may be administered
Q10: Which of the following is a marker
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents